[PDF] Top 20 Periódicos científicos digitais e ontologia : uma pesquisa

... [57, 58]. Details of these retrospective studies are sum- marized in Table 5 [59–65]. However, another retro- spective study showed that patients with SSPE have similar rate of VTE recurrence as patients with larger PE ... See full document

... of venous thromboembolism (VTE) and prevention of stroke and systemic embolism (SSE) in patients with nonvalvular atrial fibrillation ...the management of ... See full document

... Abstract: Venous thromboembolism (VTE) is a disease state that carries significant morbidity and mortality, and is a known cause of preventable death in hospitalized and orthopedic surgical ...VTE ... See full document

... or venous thromboembolism ...the management of stroke and thromboembolic disease, highlighting the key study results that have led to its current ... See full document

... of venous thromboembolism ...acute management of patients with deep-vein thrombosis to be undertaken by primary ...long-term management of these ...patient management and improve ... See full document

... Abstract: Multiple orthopedic procedures are performed each year including knee and hip replacements, also known as knee and hip arthroplasty. These procedures strongly activate the clotting cascade and increase the risk ... See full document

... Due to limited venous access conditions, pediatric patients often rely on CVAD. If a symptomatic thrombosis occurs, the patient requires CVAD and the device is functional, ASH suggests leaving the CVAD in situ ... See full document

... outpatient management of acute PE have utilised LMWH and VKA, the practical benefits of NOACs (especially the NOACs rivaroxaban and apixaban, which do not require pre- treatment with LMWH) make them an attractive ... See full document

... of venous thromboembolism (VTE), including deep vein throm- bosis (DVT) and pulmonary embolism (PE), which is a major cause of morbidity and mortality [3, ... See full document

... In light of this, it is noteworthy that there are data to sug- gest better efficacy with enoxaparin than with UFH given on a t.i.d. basis to patients with congestive heart failure (CHF). When comparing enoxaparin 40 mg ... See full document

... quantified medical and nonmedical costs related to DVT dur- ing 2 years following diagnosis in 355 consecutive patients with acute DVT recruited at seven Canadian hospital centers. Two thirds of the patients were treated ... See full document

... collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for ... See full document

... Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy (AMPLIFY) trial conducted in 5385 patients [21] and was associated with a reduction in major ... See full document

... Obesity is a major public health problem not only in the United States, but also rapidly is becoming a global threat [8]. While obesity can serve as a risk factor for some diseases, it also can affect preexisting ... See full document

... of venous thromboembolism, in the treatment of chronic venous disorders, and in the treatment of venous and arterial (stable and unstable angina, acute ST-segment elevation myocardial ... See full document

... transfusion), these findings should be interpreted with caution. Nonetheless, these data also underscore need for collaborative inputs from experts and an evidence base to propose guidelines and thresholds for transfusion ... See full document

... In the last century, recognition that all DVT risk factors reflect these underlying pathophysiologic processes and that VTE does not usually develop in their absence has increased. An understanding of the risk factors ... See full document

... the incidence of vte during childhood is low (0.07 per 10,000) (1) compared to adulthood (1 per 1,000 per year) (13). lower and delayed thrombin generation in children plasma and increased thrombin inhibition by ... See full document

... Sato et al. [33] described a case of Trousseau’s syn- drome that shows the possible contribution of TF in the pathogenesis of DVT/PE in patients with lung cancer. They observed a marked increase in plasma TF level, to- ... See full document

... Common symptoms of deep vein thrombosis in the upper and lower extremities include pain or tenderness and swelling. Signs on physical examination include increased warmth, edema, and erythema, and may also include ... See full document